Latest revenue
$9.4M
as of 2026-03-31
Latest net income
$-426.3K
as of 2026-03-31
Net margin
-4.5%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $41.8M
- Enterprise value
- $41.8M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.26
- 52-wk low
- $0.10
- Beta
- —
- Shares out
- 280.4M
5-year trend
What this company does
ITEM 1.BUSINESS Our Company Leef Brands, Inc. (Formerly Icanic Brands Company Inc.) was incorporated on September 15, 2011, under the laws of the province of British Columbia and is registered extra-provincially under the laws of Ontario. The Company is a cannabis branded products manufacturer based in California. LEEF is a public company whose common shares are listed for trading on the Canadian Securities Exchange (“CSE”) under the symbol “LEEF”. On April 20, 2022, the Company acquired all of the common shares of LEEF Holdings, Inc. (“LEEF”). LEEF is a cannabis extraction company located in the state of California and provides bulk concentrate to cannabis brands in the state of…
AI summary unavailable — showing raw filing excerpt
Generated from LEEEF's filing dated 2026-03-26
Key risks
ITEM 1A.RISK FACTORS An investment in our securities is highly speculative and subject to numerous and substantial risks. Readers are encouraged to review these risks carefully before making any investment decision. In addition to the other information provided in this filing, you should carefully consider the following risk factors in evaluating our business before purchasing any of our common shares. All material risks are discussed in this section. Risks Related to Our Financial Condition and Need for Additional Capital We have incurred net losses and cannot assure you that we will achieve or maintain profitable operations. Our net loss was $17.6 million for the year ended December 31,…
AI summary unavailable — showing raw filing excerpt
Generated from LEEEF's filing dated 2026-03-26
Profitability
Gross margin
30.1%
11.8%Operating margin
-21.8%
22.1%Net margin
-50.7%
41.3%Return on equity
213.2%
7.7%Return on assets
-48.4%
15.5%Leverage
Debt / equity
-5.40×
21.2%Long-term debt / equity
-1.18×
59.1%Debt / assets
122.7%
4.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $9.4M | -0.2% | $-426.3K | -260.4% | -4.5% |
Q1 2025 2025-03-31 | $9.4M | — | $265.8K | — | 2.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Medicinal Chemicals & Botanical Products · SIC 2833
Your notes
Keep private notes on LEEEF — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$47.6K
Insider selling
$0
Net activity
+$47.6K
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns LEEEF
No institutional holdings on file for LEEEF yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once LEEEF's latest filing finishes processing.